Zobrazeno 1 - 9
of 9
pro vyhledávání: '"W. J. Tester"'
Publikováno v:
The Prostate. 29:243-248
BACKGROUND The objective of this study was to document previously unreported anemia in prostate cancer patients treated with neoadjuvant combined androgen blockade (CAB) and pelvic radiotherapy (XRT). METHODS Four institutions treated 141 patients (m
Autor:
W J, Tester, K M, Kim, R L, Krigel, P D, Bonomi, J H, Glick, R F, Asbury, J M, Kirkwood, R H, Blum, J H, Schiller
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 25(3)
Interleukin-2 (IL-2) and beta-interferon (beta-IFN) are biologic agents with antitumor activity observed in preclinical models. Some studies of patients with advanced non-small cell lung cancer treated with IL-2 report relatively long survival, despi
Publikováno v:
Cancer. 79(4)
Single-agent chemotherapy produces partial responses in the range of 7-27% in patients with Stage IV nonsmall cell lung carcinoma (NSCLC). Cisplatin-based combination regimens have achieved higher response rates but with significant toxicity. Two pri
Publikováno v:
The Prostate. 29(4)
The objective of this study was to document previously unreported anemia in prostate cancer patients treated with neoadjuvant combined androgen blockade (CAB) and pelvic radiotherapy (XRT).Four institutions treated 141 patients (mean age +/- SD, 70.9
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 13(1)
PURPOSE The purpose of this study was to determine the maximum-tolerated dose (MTD) of fluorouracil (5-FU) administered as a protracted intravenous (IV) infusion with concurrent radiation in patients with pancreaticobiliary carcinoma. METHODS Twenty-
Publikováno v:
Journal of Clinical Oncology. 22:7293-7293
Publikováno v:
Journal of Clinical Oncology. 22:3184-3184
Autor:
Brenda Waller, Eli Glatstein, W J Tester, Timothy J. Kinsella, Robert W. Makuch, P A Kelley, V T DeVita
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2(7)
The medical records of all patients treated for Hodgkin's disease during the years 1964-1981 were reviewed. Four hundred seventy-three previously untreated patients were analyzed. Thirty-four subsequent second malignant neoplasms were observed in 33
Publikováno v:
Cancer treatment reports. 67(12)
Thirty-two patients with small cell carcinoma of the lung were given chest radiotherapy to progressive intrathoracic tumor after failing chemotherapy. Two-thirds of these patients received split-course treatment at a dose of 4000 rad in 10 fractions.